FOLLOW THE SOURCE

The research behind the profiles.

161 unique publications. 74 linked compound profiles. One place to inspect the references, find a paper and take the citation with you.

161 publications · bibliographic metadata checked 2026-09-20

Publication types and subject tags are PubMed indexing labels, not evidence grades. “Other publications” includes records without a more specific indexed type. Read the limitations.

Randomized controlled trial2023 · PMID 37364590

Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

Frias JP, Deenadayalan S, Erichsen L, et al. · Lancet

PubMed types: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't. Subject tags: Humans.

Randomized controlled trial2021 · PMID 34798060

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

Lau DCW, Erichsen L, Francisco AM, et al. · Lancet

PubMed types: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial. Subject tags: Humans.

Equivalence trial2020 · PMID 32416978

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection

Witz CA, Daftary GS, Doody KJ, et al. · Fertil Steril

PubMed types: Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't. Subject tags: Humans.

Other publication2010 · PMID 20554713

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data

Falutz J, Mamputu JC, Potvin D, et al. · J Clin Endocrinol Metab

PubMed types: Journal Article; Research Support, Non-U.S. Gov't. Subject tags: Humans.

SCOPE & PROVENANCE

A reading index with visible limits.

A bibliographic index of 161 unique PubMed records linked by 74 PeptiDex compound profiles. Contains PMID, title, authors, journal, year, DOI, PubMed publication types, Humans/Animals MeSH tags and linked profiles. This is a curated reference list, not a systematic search, evidence grade or treatment dataset.

Metadata was retrieved from NCBI PubMed E-utilities on . Publication titles, identifiers, authors and indexing tags come from those records. No abstracts or full articles are reproduced. The download adds links to the profiles that cite each publication.

A PubMed “Humans” tag does not by itself identify a randomized trial, prove a benefit, or establish that every claim in a paper concerns people. Reviews can discuss several experimental settings. Missing tags do not prove the absence of human or animal data. Read the original methods, population, formulation, endpoints and limitations.

Selection reflects the site's current reference coverage. It is not exhaustive or ranked by quality, and metadata checks do not verify every claim in a profile. Selected reading notes explain particular studies; they are not a medical review.

Compiled by Clayton Camera / PeptiDex with automated retrieval. PeptiDex and Practically Natty Peptides share ownership. See our editorial policy and evidence guide.

Citing this index

PeptiDex. Linked-publication index. Bibliographic snapshot 2026-09-20. https://www.thepeptidex.net/sources/ (include your access date). Cite the original paper when discussing its findings.

For research and educational purposes only. Not medical advice.